$ARX

Stock Market Today, Aug. 13: Accelerant Holdings Surges 43% on All-Cash Buyout Offer

Accelerant Holdings (ARX) surged about 43% to close near $19.52 after Thoma Bravo announced a definitive all-cash buyout at $20.25 per share. The company also reported stronger-than-expected Q2 results. Investors are tracking deal approval and a first-half 2027 closing timeline. Sector stocks were mixed as S&P 500 and Nasdaq rose.

Original reporting
Published Aug 13, 2026, 10:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 10:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stock Market Today, Aug. 13: Accelerant Holdings Surges 43% on All-Cash Buyout Offer — source image
Decision brief

The 30-second read

$ARXBullishHigh
01

Why it matters

The definitive all-cash offer at $20.25 per share is the primary driver of the stock’s move, shifting focus to tender mechanics and approval milestones.

02

Market read

Deal certainty language plus a premium-to-market move makes this actionable for both directional traders and merger-arb participants.

03

What to watch

The article highlights an approval progress and a 1H 2027 closing timeline, but does not discuss financing certainty, regulatory hurdles, or any potential competing bids.

Relevance 9/10Novelty 9/10Timing: after-hours/next-session repricing following the definitive all-cash buyout announcement

Background

Accelerant Holdings IPO’d in 2025 and has traded below its initial post-IPO highs, setting a context for a take-private exit.

Company-level read

Ticker impact

$ARXBullishMedium confidence
Context

Accelerant Holdings (ARX) surged about 43% after a definitive all-cash buyout offer at $20.25 per share was announced.

Expected impact

High probability of continued volatility tied to deal-approval progress; downside risk if approvals stall or terms change.

Evidence & confidence

The article cites a definitive all-cash offer price and notes the stock trading close to the take-private level, implying market focus on deal completion and approval timeline.

Market effects

Signals continued M&A appetite for specialty insurance risk exchange and software-enabled underwriting platforms.

Limited direct regional impact; primarily a US small/mid-cap deal-arb catalyst.

Moderate, as specialty insurance tech consolidation can affect global peers’ valuation expectations.

Counterpoint

A large premium does not eliminate deal risk; approval delays or conditions could compress the spread quickly.

Key entities

  • Accelerant Holdings

    Data-driven specialty insurance risk exchange platform whose shares jumped on a definitive all-cash buyout offer.

  • Thoma Bravo

    Private equity firm announcing the acquisition of Accelerant for $20.25 per share in an all-cash deal.

Related articles

$ARXHighAI 9/10

Accelerant Shares Surge 43% On Thoma Bravo Buyout Deal

Accelerant Holdings (ARX) shares rose about 43% after the company said it has a definitive agreement to be acquired by Thoma Bravo in an all-cash deal worth more than $4 billion. ARX was trading around $19.52, up $5.91, after opening near $19.61 versus a prior close of $13.61.

$ARXHighAI 9/10

Accelerant To Be Acquired By Thoma Bravo

Accelerant Holdings (ARX) agreed to be acquired by Thoma Bravo in an all-cash deal valued at over $4 billion. Accelerant shareholders will receive $20.25 per share, a 49% premium to Aug. 12’s close. The deal is expected to close in 1H 2027 and take the firm private. ARX shares rose premarket.

$ARXMedAI 8/10

Accelerant Holdings (ARX): Results of Operations and Financial Condition

Accelerant Holdings (ARX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d286225dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Accelerant Announces Second Quarter 2026 Results Accelerant Cancels Earnings Conference Call Following Announcement of Agreement with Thoma Bravo to Become a Private Company Second Quarter 2026 Results • Exchange Written Pr

$ARXMed

ARX: Q2 2026 delivered robust operational and financial results, with the Shell acquisition progressing

Less than 1 min read Q2 2026 saw strong production growth and higher realized prices, driving a 20% year-over-year increase in funds from operations and a 94% rise in free funds flow per share. Net income declined 9% per share due to lower risk management gains and higher costs. The pending $22 billion Shell acquisition remains on track. Original document: ARC Resources Ltd. [ARX] Interim report — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies.

$ARXMed

ARX: Q2 2026 delivered robust production and cash flow as the $22B Shell acquisition advances

Less than 1 min read Q2 2026 saw 9% year-over-year production growth and strong cash flow, with $816 million in funds from operations and $349 million in free funds flow. The $22 billion Shell acquisition is progressing, with closing expected in Q3 2026. Original document: ARC Resources Ltd. [ARX] Earnings Release — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Stock Market Today, Aug. 13: Accelerant Holdings Surges 43% on All-Cash Buyout Offer — alphai